Trans Genic INC. japanese
Corporate Information
News Releases
Products & Service
Investor Relations
Career
Preclinical Research Service
Genetically Engineered MiceCustom Production of Knockout MicePhenotyping Service
AntibodiesHigh-Affinity Antibody TechnologyPreclinical Research ServiceDeltagen
TOPICS



~ Business Tie-up with JSW-Research ~

The contract research service of broader rage of drug evaluation tests specialized in neurodegeneration models is newly available

Outline

Incidences of Alzheimer's and Parkinson's diseases as well as ischemic brain damage are on the rise with the increase in life expectancy in highly industrialized societies. Being equally considered 21st century as "Age of the brain", the R&D of drug of these Parkinson's diseases and Alzheimer’s disease has been intensified and research in neurodegeneration has therefore become a central field in modern biomedical research.

We provide contract research/consulting services of in vitro/in vivo preclinical research and clinical research in drug discovery of Parkinson's diseases and Alzheimer’s disease with the collaboration of JSW-Research, a R&D company having a number of actual achievements in drug R&D as well as contract research focusing on neurodegenerative disorders.

JSW-Research Ltd.

JSW-Research, Graz, Austria, founded in 1999, is a research and development company, specializing in drug development focusing on neurodegenerative disorders. Scientific technologies specialized in incidences of Alzheimer's and Parkinson's disease receive high evaluation marks and years of experience and great number of actual performances with major pharmaceutical companies have also established.


In addition, drug discovery technology using transgenic mouse or transgenic cell line which is reflected more specifically in human disease is characterized as one of their unique technology.


In vitro drug evaluation system
+ α-Synuclein cell lesion assay
+ ß-Amyloid cell lesion assay
+ Glutamate cell lesion assay
+ Iodoacetic acid cellular disorder examination
+ Glutamate cell lesion assay
+ Oxygen glucose deprivation (OGD) induced cell lesion assay
+ NMDA cell lesion assay


In vivo drug evaluation system
+ Human TAU441 transgenic mouse model (V337M, R406W, double mutation)
+ Human APP transgenic mouse model (Swedish double and London mutation)
+ Human α-synuclein transgenic mouse model

In addition, we are providing clinical research and consulting services in overseas.

JSW Research Ltd. homepage

Kobe Research Center
7-1-14 Minatojimaminami-machi, Chuo-ku, Kobe, 650-0047 Japan
 
Contact UsTerms of UseSite MapWhat's New